7 projets européens trouvés
Recherche sur 125080 projets européens
TERMINÉ
Personal Technologies for Affective Health (AffecTech)
Date du début: 1 janv. 2017, Date de fin: 31 déc. 2020,
Personalized health is a European priority and one of the strategic research areas for Horizon 2020. This project advances the state-of-the-art of personal health technologies for affective disorders, estimated to be the highest ranking cause of disease by 2020. It marks a significant shift from the current wearable technologies capturing emotional responses whose understanding usually requires ph ...
Voir le projet
12
Participants partenaires
TERMINÉ
The artificial pancreas in children aged 1 to 7 years with type 1 diabetes (KidsAP)
Date du début: 1 janv. 2017, Date de fin: 30 juin 2020,
TYPE 1 DIABETES is one of the most COMMON CHRONIC diseases in children with a RAPID increase in number of cases particularly in young children. Type 1 diabetes is associated with LIFE-LONG dependency on insulin administration. POOR glucose control leads to diabetes COMPLICATIONS, e.g. eye, heart, kidney disease, including BRAIN changes in young children. Episodes of VERY LOW glucose levels may be ...
Voir le projet
14
Participants partenaires
TERMINÉ
Providing the right care to the right patient with MyeloDysplastic Syndrome at the right time (MDS-RIGHT)
Date du début: 1 mai 2015, Date de fin: 30 avr. 2020,
Myelodysplastic syndromes (MDS) are chronic bone marrow malignancies of the elderly, complicated by severe anaemia. MDS significantly affects quality-adjusted survival and it imposes an increasing financial burden on patients and healthcare (HC) systems. The burden of disease is expected to worsen in the future, given the aging EU population and newly identified MDS cases among those diagnosed wit ...
Voir le projet
16
Participants partenaires
TERMINÉ
Engineering Solutions for Back Pain: Simulation of Patient Variance (BACKTOBACK)
Date du début: 1 déc. 2012, Date de fin: 30 nov. 2018,
Back pain affects eight out of ten adults during their lifetime. It a huge economic burden on society, estimated to cost as much as 1-2% of gross national product in several European countries. Treatments for back pain have lower levels of success and are not as technologically mature as those for other musculoskeletal disorders such as hip and knee replacement. This application proposes to tackl ...
Voir le projet
2
Participants partenaires
TERMINÉ
Silicon Nitride Coatings for Improved Implant Function (LifeLongJoints)
Date du début: 1 avr. 2013, Date de fin: 31 mars 2018,
Articulating joint replacements represent a medical market exceeding €14 billion p.a. that is expected to rise as demographics reflect an ageing population. However, faster growth has been seen in the revision market, where prosthetic joints are replaced, than in primary interventions. The major cause of these revisions is that all joint replacements are prone to wear leading to loss of implant fu ...
Voir le projet
16
Participants partenaires
TERMINÉ
PIVOTAL ASSESSMENT OF THE EFFECTS OF BIOACTIVES ON HEALTH AND WELLBEING. FROM HUMAN GENOMA TO FOOD INDUSTRY - PATHWAY (PATHWAY-27)
Date du début: 1 févr. 2013, Date de fin: 31 janv. 2018,
Scientific understanding of the role and mechanisms of bioactives is fragmented. Research often addresses the theoretical possibility of health improvement effects rather than their real, practical use for everyday diets. Bioactives cannot be considered as discrete chemical compounds and research must focus on bioactive-enriched foods (BEF), if consumer demands for foods delivering appropriate hea ...
Voir le projet
28
Participants partenaires
TERMINÉ
EUROPEAN NETWORK for CANCER research in CHILDREN and ADOLESCENTS (ENCCA)
Date du début: 1 janv. 2011, Date de fin: 31 déc. 2015,
"ENCCA aims to establish a durable, European Virtual Institute clinical and translational research in childhood and adolescent cancers that will define and implement an integrated research strategy and will facilitate the necessary investigator-driven clinical trials to introduce the new generation of biologically targeted drugs into standard of care for children and adolescents with cancer. This ...
Voir le projet